Reditux
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
using the results of the studies. In DLBCL patients, VSS and T1⁄2 − β of RedituxTM are about 80 % lower than what was reported…
مقايسه اثرات درماني وعوارض ريتوکسيماب داخلي (Reditux) بامشابه تجاري آن (MabThera) دربيماران مبتلابه لنفوم منتشرسلول بزرگ DLBCL)B…
Background: Rituximab is a chimeric IgG1 monoclonal antibody targeting the CD20 surface antigen on normal and neoplastic B cells…
volume 29 number 3 mArCH 2011 nature biotechnology With Rituxan’s patents facing expiration, the drug has become a prime target…
volume 29 number 3 mArCH 2011 nature biotechnology With Rituxan’s patents facing expiration, the drug has become a prime target…